Does Rallies show 13F holders for ATRC?

Yes. Rallies tracks hedge fund and 13F ownership data for ATRC, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ATRC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ATRC. It does not provide personalized investment advice.

ATRC (AtriCure, Inc.) Stock Analysis - Hedge Fund Holdings

AtriCure, Inc. (ATRC) is a publicly traded Healthcare sector company. As of May 21, 2026, ATRC trades at $29.00 with a market cap of $1.44B and a P/E ratio of -288.90. ATRC moved +0.69% today. Year to date, ATRC is -28.43%; over the trailing twelve months it is -14.83%. Its 52-week range spans $25.52 to $43.18. Analyst consensus is strong buy with an average price target of $50.29. Rallies surfaces ATRC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ATRC stock?

Hedge funds tracked by Rallies that own ATRC include Panagora Asset, Bridgewater Associates, Centerbook Partners, and Pinebridge Investments. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for AtriCure, Inc..

ATRC Key Metrics

Key financial metrics for ATRC
Metric	Value
Price	$29.00
Market Cap	$1.44B
P/E Ratio	-288.90
EPS	$-0.10
Dividend Yield	0.00%
52-Week High	$43.18
52-Week Low	$25.52
Volume	0
Avg Volume	0
Revenue (TTM)	$552.16M
Net Income	$-4.59M
Gross Margin	75.61%

Top Hedge Funds Holding ATRC

Panagora Asset holds 227.38K shares of ATRC, changed +0.35% as of Mar 31, 2026.
Bridgewater Associates holds 33.52K shares of ATRC, changed +70.27% as of Mar 31, 2026.
Centerbook Partners holds 6.05K shares of ATRC, changed +0.00% as of Dec 31, 2023.
Pinebridge Investments holds 100 shares of ATRC, changed +0.00% as of Jun 30, 2023.

Latest ATRC News

AtriCure Tops Q3 Revenue Estimates, Forecasts 109% FY2026 Earnings Growth — Feb 18, 2026
AtriCure Raises 2026 Revenue Guidance to $600–$610M After 13% Q4 Growth — Feb 18, 2026
AtriCure Q3 Loss Narrows 90.9%, Revenue Beats by 2.1% — Feb 17, 2026
Stryker Launches T2 Alpha Humerus Nail with 6 mm Compression — Feb 12, 2026
AtriCure Q3 Loss Narrows to $0.01; Revenue Tops $134M, 92% Growth Forecast — Feb 9, 2026

Recent ATRC Insider Trades

Doraiswamy Vinayak sold 5.00K (~$149.15K) on Mar 12, 2026.
Noznesky Justin J sold 5.17K (~$192.64K) on Nov 26, 2025.
WEHRWEIN SVEN sold 4.97K (~$188.75K) on Nov 25, 2025.

ATRC Analyst Consensus

8 analysts cover ATRC: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $50.29.

Common questions about ATRC

Who owns ATRC stock?: Hedge funds tracked by Rallies that own ATRC include Panagora Asset, Bridgewater Associates, Centerbook Partners, and Pinebridge Investments. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for AtriCure, Inc..
Does Rallies show 13F holders for ATRC?: Yes. Rallies tracks hedge fund and 13F ownership data for ATRC, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ATRC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ATRC. It does not provide personalized investment advice.